Why Argus Upgraded Vertex Pharma To Buy Last Week By: Benzinga via Benzinga September 29, 2015 at 08:07 AM EDT Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) shares are down 17 percent year-to-date, despite crossing the $140 mark twice ... Read More >> Related Stocks: Vertex Pharmaceuticals